FR2017798A1 - - Google Patents

Info

Publication number
FR2017798A1
FR2017798A1 FR6930803A FR6930803A FR2017798A1 FR 2017798 A1 FR2017798 A1 FR 2017798A1 FR 6930803 A FR6930803 A FR 6930803A FR 6930803 A FR6930803 A FR 6930803A FR 2017798 A1 FR2017798 A1 FR 2017798A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR6930803A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DSM Delft BV
Original Assignee
Koninklijke Nederlandsche Gist en Spiritusfabriek BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Koninklijke Nederlandsche Gist en Spiritusfabriek BV filed Critical Koninklijke Nederlandsche Gist en Spiritusfabriek BV
Publication of FR2017798A1 publication Critical patent/FR2017798A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C07J3/005—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
    • C07J7/0045—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/0026—Oxygen-containing hetero ring cyclic ketals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR6930803A 1968-09-11 1969-09-10 Withdrawn FR2017798A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB43295/68A GB1277886A (en) 1968-09-11 1968-09-11 Androstenones

Publications (1)

Publication Number Publication Date
FR2017798A1 true FR2017798A1 (fr) 1970-05-22

Family

ID=10428135

Family Applications (3)

Application Number Title Priority Date Filing Date
FR696930801A Expired FR2017796B1 (fr) 1968-09-11 1969-09-10
FR6930803A Withdrawn FR2017798A1 (fr) 1968-09-11 1969-09-10
FR6930802A Withdrawn FR2017797A1 (fr) 1968-09-11 1969-09-10

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR696930801A Expired FR2017796B1 (fr) 1968-09-11 1969-09-10

Family Applications After (1)

Application Number Title Priority Date Filing Date
FR6930802A Withdrawn FR2017797A1 (fr) 1968-09-11 1969-09-10

Country Status (13)

Country Link
US (1) US3585191A (fr)
BE (3) BE738668A (fr)
BR (3) BR6912309D0 (fr)
CA (1) CA958004A (fr)
DE (3) DE1945878A1 (fr)
DK (1) DK127554B (fr)
ES (4) ES371331A1 (fr)
FR (3) FR2017796B1 (fr)
GB (1) GB1277886A (fr)
IE (1) IE33607B1 (fr)
IL (3) IL32937A0 (fr)
NL (2) NL6913815A (fr)
SE (1) SE355361B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0188010A1 (fr) * 1985-01-14 1986-07-23 Gist-Brocades N.V. Procédé de préparation de stéroides, en particulier d'intermédiaires dans la préparation de proligestone et de composés apparentés et composés obtenus par ce procédé

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3905962A (en) * 1970-03-06 1975-09-16 Arthur Friedrich Marx Oestratrienes
DE2748442C3 (de) * 1977-10-26 1981-08-27 Schering Ag Berlin Und Bergkamen, 1000 Berlin 17α-(3-Jodbenzoyloxy)-9α -chlor4-pregnen-3.20-dione, Zwischenprodukte und Verfahren zu ihrer Herstellung, 9α -chlor-17α, 21-dihydroxy-1,4-pregnadien-3,20-dion und dieses enthaltende Arzneimittel

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0188010A1 (fr) * 1985-01-14 1986-07-23 Gist-Brocades N.V. Procédé de préparation de stéroides, en particulier d'intermédiaires dans la préparation de proligestone et de composés apparentés et composés obtenus par ce procédé
EP0189951A1 (fr) * 1985-01-14 1986-08-06 Akzo N.V. Procédé de préparation de stéroides, en particulier d'intermédiaires dans la préparation de proligestone et de composés apparentés et les nouveaux intermédiaires obtenus par ce procédé

Also Published As

Publication number Publication date
DK127554B (da) 1973-11-26
ES381473A1 (es) 1972-11-16
IL32935A0 (en) 1969-11-30
BE738668A (fr) 1970-03-10
IE33607L (en) 1970-03-11
DE1945879A1 (de) 1970-03-19
DE1945878A1 (de) 1970-03-19
GB1277886A (en) 1972-06-14
CA958004A (en) 1974-11-19
ES371330A1 (es) 1971-10-16
ES371331A1 (es) 1971-10-16
IL32935A (en) 1973-08-29
NL6913816A (fr) 1970-03-13
SE355361B (fr) 1973-04-16
NL6913815A (fr) 1970-03-13
FR2017796A1 (fr) 1970-05-22
ES371332A1 (es) 1971-10-16
BR6912307D0 (pt) 1973-05-10
BE738666A (fr) 1970-03-10
BE738667A (fr) 1970-03-10
IL32937A0 (en) 1969-11-30
BR6912309D0 (pt) 1973-03-13
BR6912308D0 (pt) 1973-04-12
DE1945877A1 (de) 1970-07-23
FR2017797A1 (fr) 1970-05-22
US3585191A (en) 1971-06-15
IL32936A0 (en) 1969-11-30
IE33607B1 (en) 1974-09-04
FR2017796B1 (fr) 1973-07-13

Similar Documents

Publication Publication Date Title
AU5506869A (fr)
AU5184069A (fr)
AU6168869A (fr)
AU6171569A (fr)
FR2017796B1 (fr)
AU2581067A (fr)
AU2952567A (fr)
AU4811568A (fr)
AU4744468A (fr)
AU3789668A (fr)
BE709496A (fr)
AU2889368A (fr)
BE728035A (fr)
BE727812A (fr)
BE727743A (fr)
BE727557A (fr)
BE726436A (fr)
BE728613A (fr)
AU5758767A (fr)
AU479894A (fr)
BE581157A (fr)
BE724583A (fr)
BE724055A (fr)
BE719119A (fr)
BE718056A (fr)

Legal Events

Date Code Title Description
ST Notification of lapse